Pharmetics recalls six OTC products in Canada
The recall is a consequence of Health Canada’s Good Manufacturing Practices (GMP) inspection at the company’s Laval manufacturing site where deficiencies in the production line were detected. Possible
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
mPhase claims that its Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. The
RADIANT-3, a prospective, double-blind, randomized, parallel group, placebo-controlled, multicenter study, examined the efficacy and safety of everolimus plus BSC versus placebo plus BSC in 410 patients with advanced,